With 90% of the patients having adenocarcinoma histology, our data confirmed that KRAS mutations were uncommon in other lung cancer subtypes but could even be found in neuroendocrine and squamous cell tumors in rare cases. This evidence concerns the gene KRAS and squamous cell neoplasm.